Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Dystrophin ELISA Kit (AC3642)
Cat.#: ASET-2231
Specifications
Description Human Dystrophin ELISA Kit allows for the in vitro quantitative determination of human Dystrophin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2131 Rat Pofut1 ELISA Kit (AC3542) Quantitative inquiry ASET-2478 Human RAMP1 ELISA Kit (AC3889) Quantitative inquiry ASET-1345 Mouse Prealbumin ELISA Kit (AC2756) Quantitative inquiry ASET-1859 Human G-Protein Coupled Receptor 30 ELISA Kit (AC3270) Quantitative inquiry ASET-1085 Sheep Leptin ELISA Kit (AC2496) Quantitative inquiry ASET-2460 Human SHC ELISA Kit (AC3871) Quantitative inquiry ASET-1760 Human GLP-1R ELISA Kit (AC3171) Quantitative inquiry ASET-1110 Mouse ABCA1 ELISA Kit (AC2521) Quantitative inquiry ASET-2075 Human PROKR2 ELISA Kit (AC3486) Quantitative inquiry ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket